Comparative efficacy and safety of atorvastatin, simvastatin and lovastatin in the management of dyslipidemic Type 2 diabetic patients

By Hadjibabaie Molouk   Gholami Kheirollah   Khalili Hossain   Khoei Seyed Hamid   Nakhjavani Manoochehr   Rayati Kobra   Tohidi Atefeh   Rahimi Roja   Abdollahi Mohammad  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 759-764

Future Medicine

Access to resources Recommend Favorite

Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA_1c predicts dyslipidaemia

By Khan H.   Sobki S.   Khan S.  

Clinical and Experimental Medicine, Vol. 7, Iss. 1, 2007-03 ,pp. : 24-29

Springer Publishing Company

Access to resources Recommend Favorite

The effect of simvastatin on triglyceride-rich lipoproteins in patients with type 2 diabetic dyslipidemia: a SILHOUETTE Trial Sub-study

By Miller M.   Dobs A.   Yuan Z.   Battisti W. P.   Palmisano J.  

Current Medical Research and Opinion, Vol. 22, Iss. 2, 2006-02 ,pp. : 343-350

Informa Healthcare

Access to resources Recommend Favorite

Diabetic dyslipidaemia: insights for optimizing patient management

By Vergès B.  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 29-40

Informa Healthcare

Access to resources Recommend Favorite

Lifestyles and oxidative stress in type 2 diabetic patients

By Kotani Kazuhiko   Sakane Naoki   Tsuzaki Kokoro   Matsuoka Yukiyo   Sano Yoshiko   Hamada Taku   Yamada Kazunori  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 7, 2008-01 ,pp. : 516-518

Informa Healthcare

Access to resources Recommend Favorite